<!DOCTYPE html>
<html lang="en" data-theme="dark">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="AMR Nexus — a futuristic single‑page site on Antimicrobial Resistance (AMR): diagnostics, remedial measures, case analysis, and curated research links." />
  <title>AMR Nexus • Futuristic BioTech</title>
  <style>
    /* -------------------- CSS RESET / BASE -------------------- */
    *,*::before,*::after{box-sizing:border-box}
    html,body{height:100%}
    body{margin:0;line-height:1.6;-webkit-font-smoothing:antialiased;}
    img,svg,canvas{max-width:100%;display:block}
    :root{
      --bg-0:#0a0f1f; --bg-1:#0f1329; --panel:#0f172aCC; --glass:rgba(15,23,42,.6);
      --text:#E5F4FF; --muted:#a5b4fc; --accent:#7cf9d2; --accent-2:#a78bfa; --danger:#ff6b6b;
      --shadow:0 10px 30px rgba(0,0,0,.5);
      --radius:18px;
    }
    [data-theme="light"]{
      --bg-0:#f6f8ff; --bg-1:#eaefff; --panel:#ffffffE6; --glass:rgba(255,255,255,.7);
      --text:#091123; --muted:#4f46e5; --accent:#0ea5e9; --accent-2:#8b5cf6; --danger:#ef4444;
      --shadow:0 10px 30px rgba(0,0,0,.1);
    }
    body{
      font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Inter, "Helvetica Neue", Arial, "Noto Sans", "Apple Color Emoji", "Segoe UI Emoji";
      color:var(--text); background:radial-gradient(1200px 600px at 80% -10%,#2b2d55 0%, transparent 60%),
      radial-gradient(900px 500px at -10% 10%, #1b1d3a 0%, transparent 60%),
      linear-gradient(180deg, var(--bg-0), var(--bg-1));
      overflow-x:hidden;
    }
    a{color:var(--accent)} a:hover{opacity:.9}
    .container{width:min(1200px,92vw);margin-inline:auto}

    /* -------------------- HEADER -------------------- */
    header{
      position:sticky; top:0; z-index:50; backdrop-filter:saturate(160%) blur(8px);
      background:linear-gradient(180deg, var(--glass), transparent); border-bottom:1px solid rgba(255,255,255,.06);
    }
    .nav{display:flex;align-items:center;justify-content:space-between;gap:16px;padding:14px 0}
    .brand{display:flex;align-items:center;gap:10px; font-weight:800; letter-spacing:.4px}
    .brand .logo{width:34px;height:34px;background:
      conic-gradient(from 220deg, var(--accent), var(--accent-2), #66ccff, var(--accent));
      border-radius:12px; box-shadow:0 0 30px rgba(124,249,210,.35)}
    nav ul{display:flex;gap:14px;flex-wrap:wrap;list-style:none;margin:0;padding:0}
    nav a{display:inline-block;padding:8px 12px;border-radius:999px; text-decoration:none; color:var(--text);opacity:.88;border:1px solid rgba(255,255,255,.07)}
    nav a.active, nav a:focus-visible{outline:none; border-color:var(--accent); box-shadow:0 0 0 2px rgba(124,249,210,.2)}
    .actions{display:flex;gap:10px;align-items:center}
    .btn{cursor:pointer;border:1px solid rgba(255,255,255,.1);background:linear-gradient(180deg, rgba(255,255,255,.06), rgba(255,255,255,.02));
      color:var(--text); padding:8px 12px;border-radius:10px; transition:.2s transform}
    .btn:hover{transform:translateY(-1px)}
    .btn.primary{border-color:transparent;background:
      linear-gradient(180deg, rgba(255,255,255,.1), rgba(255,255,255,.02)),
      linear-gradient(90deg, var(--accent), var(--accent-2)); color:#08121c; font-weight:700}

    /* -------------------- HERO -------------------- */
    .hero{position:relative; padding:80px 0 40px 0}
    .grid-hero{display:grid; grid-template-columns:1.1fr .9fr; gap:36px; align-items:center}
    .pill{display:inline-flex; gap:8px; align-items:center; border:1px solid rgba(255,255,255,.12); padding:6px 10px;border-radius:999px; font-size:.9rem; opacity:.9}
    .headline{font-size:clamp(32px,6vw,64px); line-height:1.05; margin:10px 0}
    .sub{font-size:1.1rem; opacity:.9}
    .neon{color:var(--accent)}
    .panel{background:var(--panel); border:1px solid rgba(255,255,255,.08); border-radius:var(--radius); box-shadow:var(--shadow)}
    .panel.pad{padding:22px}
    .kpi{display:grid; grid-template-columns:repeat(3,1fr); gap:14px; margin-top:18px}
    .kpi .box{background:linear-gradient(180deg, rgba(255,255,255,.06), rgba(255,255,255,.02)); text-align:center; padding:14px; border-radius:14px; border:1px solid rgba(255,255,255,.06)}
    .kpi .box b{font-size:1.2rem}

    /* -------------------- SECTIONS -------------------- */
    section{scroll-margin-top:90px; padding:64px 0}
    .section-title{font-size:clamp(22px,4vw,36px); margin:0 0 6px}
    .section-kicker{opacity:.7; margin-bottom:22px}

    /* Diagnostics grid */
    .toolbar{display:flex;gap:12px;flex-wrap:wrap;align-items:center;margin:18px 0}
    .input{flex:1; min-width:240px; background:rgba(255,255,255,.04); border:1px solid rgba(255,255,255,.08); color:var(--text); border-radius:10px; padding:10px 12px}
    .cards{display:grid; grid-template-columns:repeat(3,1fr); gap:18px}
    @media (max-width:980px){.grid-hero{grid-template-columns:1fr}.cards{grid-template-columns:repeat(2,1fr)}}
    @media (max-width:620px){.cards{grid-template-columns:1fr}}
    .card{position:relative; overflow:hidden}
    .card::after{content:""; position:absolute; inset:-2px; border-radius:inherit; padding:1px; background:linear-gradient(110deg, transparent, rgba(124,249,210,.35) 35%, transparent 60%); -webkit-mask:linear-gradient(#000 0 0) content-box, linear-gradient(#000 0 0); -webkit-mask-composite:xor; mask-composite:exclude}
    .card h3{margin:0 0 6px}
    .card .tag{display:inline-flex; gap:6px; align-items:center;opacity:.9;background:rgba(124,249,210,.12); border:1px solid rgba(124,249,210,.28); color:var(--accent); padding:4px 8px; border-radius:999px; font-size:.8rem; font-weight:600}
    details{border-top:1px dashed rgba(255,255,255,.12); margin-top:10px; padding-top:10px}

    /* Case area */
    .timeline{display:grid; gap:12px; margin:16px 0}
    .tl-item{display:grid; grid-template-columns:120px 1fr; gap:12px; align-items:start}
    .tl-item time{opacity:.7}
    canvas.chart{width:100%; height:280px; background:linear-gradient(180deg, rgba(255,255,255,.03), rgba(255,255,255,.01)); border:1px solid rgba(255,255,255,.08); border-radius:12px}

    /* Papers list */
    .papers{display:grid; gap:14px}
    .paper{display:grid; gap:6px; padding:14px; border-radius:14px; background:linear-gradient(180deg, rgba(255,255,255,.05), rgba(255,255,255,.02)); border:1px solid rgba(255,255,255,.08)}
    .paper .meta{font-size:.9rem; opacity:.8}

    /* Footer */
    footer{padding:48px 0; border-top:1px solid rgba(255,255,255,.08); background:linear-gradient(0deg, var(--glass), transparent)}

    /* Floating UI */
    #toTop{position:fixed; bottom:22px; right:22px; z-index:60; display:none}

    /* Reduced motion */
    @media (prefers-reduced-motion:reduce){
      .float, .softpulse {animation:none!important}
    }
  </style>
</head>
<body>
  <canvas id="bg" aria-hidden="true"></canvas>
  <header>
    <div class="container nav">
      <div class="brand"><div class="logo" aria-hidden="true"></div><span>AMR Nexus</span></div>
      <nav aria-label="Primary">
        <ul>
          <li><a href="#home" class="active">Home</a></li>
          <li><a href="#diagnostics">Diagnostic Methods</a></li>
          <li><a href="#remedies">Remedial Measures</a></li>
          <li><a href="#cases">Case Analysis</a></li>
          <li><a href="#papers">Research Links</a></li>
        </ul>
      </nav>
      <div class="actions">
        <button class="btn" id="themeBtn" title="Toggle theme">🌗</button>
        <a class="btn primary" href="#papers">Explore</a>
      </div>
    </div>
  </header>

  <main>
    <!-- -------------------- HERO -------------------- -->
    <section id="home" class="hero">
      <div class="container grid-hero">
        <div>
          <span class="pill">Topic • <b class="neon">Antimicrobial Resistance (AMR)</b></span>
          <h1 class="headline">BioTech, but <span class="neon"></span>. Track, detect & outsmart resistance.</h1>
          <p class="sub">AMR occurs when microbes evolve to evade our drugs. This site introduces modern diagnostics, practical counter‑measures, a realistic case walkthrough, and curated papers to dive deeper. Content is original and written for learning—not medical advice.</p>
          <div class="kpi">
            <div class="box"><b>Rapid ID</b><div>Minutes with MALDI‑TOF / PCR</div></div>
            <div class="box"><b>Stewardship</b><div>AWaRe‑guided prescribing</div></div>
            <div class="box"><b>One Health</b><div>Human • Animal • Environment</div></div>
          </div>
        </div>
        <div class="panel pad" aria-label="AMR data sketch">
          <svg viewBox="0 0 560 380" role="img" aria-labelledby="dnaTitle dnaDesc">
            <title id="dnaTitle">AMR Futuristic Visualization</title>
            <desc id="dnaDesc">DNA helix lines with nodes representing resistance genes and MIC trends.</desc>
            <defs>
              <linearGradient id="g1" x1="0" x2="1">
                <stop offset="0" stop-color="var(--accent)"/>
                <stop offset="1" stop-color="var(--accent-2)"/>
              </linearGradient>
              <filter id="glow"><feGaussianBlur stdDeviation="3" result="b"/><feMerge><feMergeNode in="b"/><feMergeNode in="SourceGraphic"/></feMerge></filter>
            </defs>
            <rect x="0" y="0" width="560" height="380" rx="16" fill="url(#g1)" opacity=".05"/>
            <g stroke="url(#g1)" opacity=".95" filter="url(#glow)">
              <!-- stylized helix -->
              <path d="M20,60 C140,160 420,-40 540,60" fill="none" stroke-width="2"/>
              <path d="M20,320 C140,220 420,420 540,320" fill="none" stroke-width="2"/>
              <!-- rungs -->
              <g opacity=".7">
                <path d="M60,190 l440,0" stroke-width="1"/>
                <path d="M120,140 l320,0" stroke-width="1"/>
                <path d="M160,240 l280,0" stroke-width="1"/>
                <path d="M80,100 l360,0" stroke-width="1"/>
                <path d="M100,280 l360,0" stroke-width="1"/>
              </g>
            </g>
            <!-- nodes -->
            <g fill="url(#g1)" opacity=".9">
              <circle cx="80" cy="100" r="4"/>
              <circle cx="260" cy="140" r="5"/>
              <circle cx="420" cy="240" r="4"/>
              <circle cx="500" cy="190" r="5"/>
              <circle cx="360" cy="280" r="4"/>
            </g>
            <!-- tiny legend -->
            <g fill="currentColor" opacity=".8">
              <text x="20" y="360" font-size="12">MIC↓ responsive • MIC↑ resistant</text>
            </g>
          </svg>
        </div>
      </div>
    </section>

    <!-- -------------------- DIAGNOSTIC METHODS -------------------- -->
    <section id="diagnostics">
      <div class="container">
        <p class="section-kicker">Clinical & Genomic</p>
        <h2 class="section-title">Diagnostic Methods</h2>
        <div class="toolbar">
          <input id="diagSearch" class="input" placeholder="Filter methods (e.g., MALDI, PCR, WGS, MIC)…" aria-label="Filter diagnostic methods" />
          <button class="btn" id="expandAll">Expand all</button>
          <button class="btn" id="collapseAll">Collapse all</button>
        </div>
        <div class="cards" id="diagCards" role="list">

          <!-- Card template: each is original copy -->
          <article class="panel pad card" role="listitem" data-tags="phenotypic mic broth etest euCAST CLSI culture">
            <div class="tag">Phenotypic</div>
            <h3>Antimicrobial Susceptibility Testing (AST)</h3>
            <p>Gold‑standard growth‑based assays that quantify inhibition by a drug. Common formats include disk diffusion, gradient strips, and broth microdilution to report MIC (minimum inhibitory concentration) with EUCAST/CLSI breakpoints.</p>
            <details><summary>Where it shines</summary>
              <ul>
                <li>Directly measures <b>phenotypic</b> response (what the bug actually does).</li>
                <li>Supports de‑escalation and targeted therapy once culture is positive.</li>
              </ul>
              <p><i>Limitations:</i> culture time (hours–days), special handling for fastidious organisms.</p>
            </details>
          </article>

          <article class="panel pad card" role="listitem" data-tags="rapid id ms maldi toff clinical">
            <div class="tag">Rapid ID</div>
            <h3>MALDI‑TOF MS Identification</h3>
            <p>Matrix‑assisted laser desorption/ionization time‑of‑flight quickly fingerprints microbial proteins to identify species from culture in minutes; coupling with targeted tests can flag specific resistance mechanisms.</p>
            <details><summary>Where it shines</summary>
              <ul>
                <li>Minutes‑level turnaround for species ID in routine labs.</li>
                <li>High accuracy and reduced per‑sample cost after instrument purchase.</li>
              </ul>
              <p><i>Limitations:</i> identification ≠ susceptibility; still relies on AST to quantify resistance.</p>
            </details>
          </article>

          <article class="panel pad card" role="listitem" data-tags="molecular pcr qpcr lamp carbapenemase mrsa gene">
            <div class="tag">Molecular</div>
            <h3>PCR / qPCR / LAMP Targets</h3>
            <p>Amplification assays detect resistance genes (e.g., <i>mecA</i>, <i>bla<sub>KPC</sub></i>, <i>bla<sub>NDM</sub></i>) or species‑specific markers from colonies or some primary samples, supporting early isolation and therapy choices.</p>
            <details><summary>Where it shines</summary>
              <ul>
                <li>Hours instead of days for high‑value resistance mechanisms.</li>
                <li>Useful for infection prevention screening (e.g., MRSA carriage).</li>
              </ul>
              <p><i>Limitations:</i> targeted—will miss unknown or off‑panel mechanisms; gene ≠ expression.</p>
            </details>
          </article>

          <article class="panel pad card" role="listitem" data-tags="genomics wgs ngs resistome snp surveillance outbreak">
            <div class="tag">Genomics</div>
            <h3>Whole‑Genome Sequencing (WGS)</h3>
            <p>Short/long‑read sequencing identifies species, strain, resistome, and relatedness for outbreak tracing. Increasingly used to predict susceptibility and monitor clonal spread when paired with good metadata.</p>
            <details><summary>Where it shines</summary>
              <ul>
                <li>Comprehensive view of resistance, virulence, and transmission.</li>
                <li>Enables hospital and national surveillance programs.</li>
              </ul>
              <p><i>Limitations:</i> infrastructure and bioinformatics needs; genotype–phenotype gaps remain for some drugs.</p>
            </details>
          </article>

          <article class="panel pad card" role="listitem" data-tags="metagenomics culture independent polymicrobial">
            <div class="tag">Culture‑independent</div>
            <h3>Metagenomic Sequencing</h3>
            <p>Direct sequencing from clinical specimens can identify pathogens and resistance markers in complex or culture‑negative infections.</p>
            <details><summary>Where it shines</summary>
              <ul>
                <li>Hard‑to‑grow organisms or mixed infections.</li>
                <li>Potentially faster when culture fails.</li>
              </ul>
              <p><i>Limitations:</i> host background, contamination control, and interpretation complexity.</p>
            </details>
          </article>

          <article class="panel pad card" role="listitem" data-tags="phenotypic rapid carbapenemase carba np lateral flow">
            <div class="tag">Rapid phenotypic</div>
            <h3>Enzyme & Lateral‑Flow Tests</h3>
            <p>Colorimetric or immunochromatographic assays (e.g., Carba NP, lateral‑flow for OXA‑48/KPC/NDM) detect specific resistance enzymes within hours.</p>
            <details><summary>Where it shines</summary>
              <ul>
                <li>Fast flagging of critical resistance for IPC and therapeutics.</li>
                <li>Simple workflow; useful in resource‑limited settings.</li>
              </ul>
            </details>
          </article>

        </div>
      </div>
    </section>

    <!-- -------------------- REMEDIAL MEASURES -------------------- -->
    <section id="remedies">
      <div class="container">
        <p class="section-kicker">Actionable Counter‑Measures</p>
        <h2 class="section-title">Remedial Measures</h2>
        <div class="cards">
          <article class="panel pad card">
            <div class="tag">Stewardship</div>
            <h3>Antimicrobial Stewardship (the 5 D’s)</h3>
            <ul>
              <li><b>Right Dx</b> (accurate diagnosis) → use diagnostics early.</li>
              <li><b>Right Drug</b> (AWaRe‑guided selection).</li>
              <li><b>Right Dose</b> (PK/PD aware), <b>Right Duration</b>, <b>Right De‑escalation</b>.</li>
            </ul>
            <p>Programs align prescribing to evidence and local resistance data; they reduce mortality, toxicity, and costs.</p>
          </article>

          <article class="panel pad card">
            <div class="tag">IPC</div>
            <h3>Infection Prevention & Control</h3>
            <p>Hand hygiene, catheter stewardship, isolation, environmental cleaning, and <b>vaccination</b> lower infection burden and resistance selection. WASH improvements matter across hospitals and communities.</p>
          </article>

          <article class="panel pad card">
            <div class="tag">Therapeutics</div>
            <h3>Next‑gen Options</h3>
            <ul>
              <li><b>New/Reserve antibiotics</b> with stewardship guardrails.</li>
              <li><b>Phage therapy</b> (personalized cocktails; often adjunctive).</li>
              <li><b>CRISPR‑based antimicrobials</b> (experimental, targeted killing).</li>
              <li>Synergy combos, β‑lactam/β‑lactamase inhibitors, and immune adjuncts.</li>
            </ul>
          </article>

          <article class="panel pad card">
            <div class="tag">Systems</div>
            <h3>Surveillance & One Health</h3>
            <p>Use hospital antibiograms and contribute to national programs (e.g., WHO GLASS) spanning human, animal, and environmental sectors. Link stewardship metrics with consumption (AWaRe) targets.</p>
          </article>
        </div>
      </div>
    </section>

    <!-- -------------------- CASE ANALYSIS -------------------- -->
    <section id="cases">
      <div class="container">
        <p class="section-kicker">Worked Example</p>
        <h2 class="section-title">Case Analysis — ESBL <i>E. coli</i> Bloodstream Infection</h2>
        <div class="panel pad">
          <p><b>Scenario.</b> A 62‑year‑old with fever, flank pain, and hypotension. Labs: WBC 18×10<sup>9</sup>/L, CRP 180 mg/L, lactate 3.1 mmol/L. Urine and two blood cultures collected. Empiric therapy: ceftriaxone + amikacin; fluids and source control.</p>
          <div class="timeline">
            <div class="tl-item"><time>Day 1</time><div>Urinalysis positive; bedside ultrasound suggests obstructive uropathy; stent placed. MALDI‑TOF IDs <i>E. coli</i> from urine at 18h.</div></div>
            <div class="tl-item"><time>Day 2</time><div>Blood culture flags positive; AST shows ESBL phenotype (resistant to 3GC). Therapy escalated to <b>meropenem</b>. Patient stabilizes.</div></div>
            <div class="tl-item"><time>Day 4</time><div>MIC panel returns; susceptible to piperacillin‑tazobactam and ertapenem. De‑escalate to <b>ertapenem</b>; plan total 7–10 days based on clinical course.</div></div>
            <div class="tl-item"><time>Day 7</time><div>Afebrile; CRP and WBC improved; discharge with OPAT plan and follow‑up.
            </div></div>
          </div>
          <canvas id="caseChart" class="chart" aria-label="Inflammation markers over time" role="img"></canvas>
          <p class="meta" style="opacity:.8;margin-top:8px">Illustrative case for education only. Therapeutic decisions must follow local guidelines and clinician judgment.</p>
        </div>
      </div>
    </section>

    <!-- -------------------- RESEARCH LINKS -------------------- -->
    <section id="papers">
      <div class="container">
        <p class="section-kicker">Read Further</p>
        <h2 class="section-title">Curated Research & Policy Links</h2>
        <div class="toolbar">
          <input id="paperSearch" class="input" placeholder="Search titles or keywords (e.g., GLASS, phage, AWaRe)…" aria-label="Filter research links" />
          <button class="btn" id="copyVisible">Copy visible links</button>
        </div>
        <div class="papers" id="paperList" role="list">
          <!-- Items populated below are from authoritative sources and formatted manually (original summaries). -->

          <article class="paper" role="listitem" data-tags="who factsheet overview 2019 2023">
            <strong>WHO Fact Sheet: Antimicrobial Resistance</strong>
            <div class="meta">World Health Organization (2023, updated). Global overview of AMR burden and drivers.</div>
            <a href="https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance" target="_blank" rel="noopener">who.int • Fact sheet</a>
          </article>

          <article class="paper" role="listitem" data-tags="global burden lancet 2019 study estimates">
            <strong>Global burden of bacterial AMR in 2019</strong>
            <div class="meta">The Lancet (2022). Comprehensive mortality & morbidity estimates across 204 countries.</div>
            <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext" target="_blank" rel="noopener">thelancet.com • Article</a>
          </article>

          <article class="paper" role="listitem" data-tags="trend 1990 2021 lancet 2024">
            <strong>Global AMR mortality 1990–2021</strong>
            <div class="meta">The Lancet (2024). Trends over three decades by pathogen and region.</div>
            <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01867-1/fulltext" target="_blank" rel="noopener">thelancet.com • Article</a>
          </article>

          <article class="paper" role="listitem" data-tags="cdc us threats 2019 report">
            <strong>Antibiotic Resistance Threats in the United States</strong>
            <div class="meta">CDC (2019). U.S. burden and priority pathogens; accessible graphics and data.</div>
            <a href="https://ndc.services.cdc.gov/wp-content/uploads/Antibiotic-Resistance-Threats-in-the-United-States-2019.pdf" target="_blank" rel="noopener">cdc.gov • PDF report</a>
          </article>

          <article class="paper" role="listitem" data-tags="glass surveillance who antimicrobial consumption amu amr">
            <strong>WHO GLASS: Global AMR & Antimicrobial Use Surveillance</strong>
            <div class="meta">WHO (2025). Program and latest report on antibiotic use and resistance monitoring.</div>
            <a href="https://www.who.int/publications/i/item/9789240108127" target="_blank" rel="noopener">who.int • GLASS report</a>
          </article>

          <article class="paper" role="listitem" data-tags="aware classification stewardship access watch reserve who">
            <strong>WHO AWaRe classification of antibiotics</strong>
            <div class="meta">WHO (2023). Stewardship tool to monitor and optimize antibiotic consumption.</div>
            <a href="https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.04" target="_blank" rel="noopener">who.int • Policy tool</a>
          </article>

          <article class="paper" role="listitem" data-tags="maldi tof identification review 2024 clinical microbiology">
            <strong>MALDI‑TOF in the real‑life diagnostic lab</strong>
            <div class="meta">Calderaro et&nbsp;al. (2024). Mini‑review of MALDI‑TOF MS in clinical microbiology.</div>
            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10892259/" target="_blank" rel="noopener">ncbi.nlm.nih.gov • Open access</a>
          </article>

          <article class="paper" role="listitem" data-tags="crispr antimicrobials review 2023 2024">
            <strong>CRISPR‑based antimicrobials</strong>
            <div class="meta">Mayorga‑Ramos et&nbsp;al. (2023) and de&nbsp;la&nbsp;Fuente&nbsp;Tagarro et&nbsp;al. (2024). Concepts and delivery challenges.</div>
            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10353011/" target="_blank" rel="noopener">2023 review</a> ·
            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11672446/" target="_blank" rel="noopener">2024 review</a>
          </article>

          <article class="paper" role="listitem" data-tags="phage therapy clinical outcomes 2024 nature">
            <strong>Personalized bacteriophage therapy: outcomes for 100 patients</strong>
            <div class="meta">Pirnay et&nbsp;al. (2024). Clinical improvement and eradication rates with adjunctive phage therapy.</div>
            <a href="https://www.nature.com/articles/s41564-024-01705-x" target="_blank" rel="noopener">nature.com • Article</a>
          </article>

        </div>
      </div>
    </section>

  </main>

  <footer>
    <div class="container">
      <p><b>AMR Nexus</b> — educational website template. Built with semantic HTML, modern CSS, and vanilla JS. Content is original; please consult cited sources and local guidelines before clinical use.</p>
      <p>Theme: Futuristic neon + glassmorphism. Keyboard navigation supported. <button id="printBtn" class="btn">Print / Save to PDF</button></p>
    </div>
  </footer>

  <button id="toTop" class="btn">↑ Top</button>

  <script>
    // -------------------- NAV ACTIVE STATE --------------------
    const links=[...document.querySelectorAll('nav a')];
    const sections=links.map(a=>document.querySelector(a.getAttribute('href')));
    const io=new IntersectionObserver(entries=>{
      entries.forEach(e=>{ if(e.isIntersecting){
        links.forEach(l=>l.classList.toggle('active', l.getAttribute('href')==='#'+e.target.id));
      }});
    },{rootMargin:'-50% 0px -45% 0px', threshold:[0,1]});
    sections.forEach(s=>io.observe(s));

    // -------------------- THEME TOGGLE --------------------
    const themeBtn=document.getElementById('themeBtn');
    const prefersLight=window.matchMedia('(prefers-color-scheme: light)');
    const apply=(t)=>document.documentElement.setAttribute('data-theme',t);
    const saved=localStorage.getItem('theme');
    apply(saved? saved : (prefersLight.matches? 'light':'dark'));
    themeBtn.onclick=()=>{const t=document.documentElement.getAttribute('data-theme')==='dark'?'light':'dark'; apply(t); localStorage.setItem('theme',t)}

    // -------------------- PARTICLE BACKGROUND --------------------
    const bg=document.getElementById('bg');
    const ctx=bg.getContext('2d');
    let pxRatio=window.devicePixelRatio||1; let W,H; let nodes=[];
    function resize(){W=bg.clientWidth=window.innerWidth; H=bg.clientHeight=window.innerHeight; bg.width=W*pxRatio; bg.height=H*pxRatio; ctx.setTransform(pxRatio,0,0,pxRatio,0,0)}
    window.addEventListener('resize',resize,{passive:true}); resize();
    function spawn(){nodes=Array.from({length:80},()=>({x:Math.random()*W,y:Math.random()*H,vx:(Math.random()-.5)*.4,vy:(Math.random()-.5)*.4,r:1+Math.random()*2}));}
    spawn();
    function step(){ctx.clearRect(0,0,W,H); ctx.globalAlpha=.8; 
      for(let i=0;i<nodes.length;i++){
        const n=nodes[i]; n.x+=n.vx; n.y+=n.vy; if(n.x<0||n.x>W) n.vx*=-1; if(n.y<0||n.y>H) n.vy*=-1;
        ctx.beginPath(); ctx.arc(n.x,n.y,n.r,0,Math.PI*2); ctx.fillStyle='rgba(124,249,210,.8)'; ctx.fill();
        // connect nearby
        for(let j=i+1;j<nodes.length;j++){
          const m=nodes[j]; const dx=n.x-m.x, dy=n.y-m.y; const d=Math.hypot(dx,dy);
          if(d<120){ ctx.strokeStyle='rgba(167,139,250,.15)'; ctx.lineWidth=1; ctx.beginPath(); ctx.moveTo(n.x,n.y); ctx.lineTo(m.x,m.y); ctx.stroke(); }
        }
      }
      requestAnimationFrame(step);
    }
    step();

    // -------------------- FILTERABLE CARDS --------------------
    function attachFilter(inputId, listId, itemSelector){
      const input=document.getElementById(inputId); const list=document.getElementById(listId);
      input.addEventListener('input',()=>{
        const q=input.value.trim().toLowerCase();
        list.querySelectorAll(itemSelector).forEach(el=>{
          const text=el.textContent.toLowerCase()+ ' ' + (el.dataset.tags||'');
          el.style.display = text.includes(q)? 'grid':'none';
        });
      });
    }
    attachFilter('diagSearch','diagCards','.card');
    attachFilter('paperSearch','paperList','.paper');

    // expand/collapse details in diagnostics
    const expandAll=document.getElementById('expandAll');
    const collapseAll=document.getElementById('collapseAll');
    expandAll.onclick=()=>document.querySelectorAll('#diagCards details').forEach(d=>d.open=true);
    collapseAll.onclick=()=>document.querySelectorAll('#diagCards details').forEach(d=>d.open=false);

    // -------------------- CASE CHART (vanilla canvas) --------------------
    const c=document.getElementById('caseChart'); const cx=c.getContext('2d');
    function drawChart(){
      const dpr=window.devicePixelRatio||1; const w=c.clientWidth, h=280; c.width=w*dpr; c.height=h*dpr; cx.setTransform(dpr,0,0,dpr,0,0);
      const pad=40; const W=w-pad*2; const H=h-pad*2;
      // Example data: CRP (mg/L), WBC (x10^9/L) scaled to same axis for demo
      const days=[1,2,3,4,5,6,7];
      const crp=[180, 160, 130, 90, 70, 50, 30];
      const wbc=[18, 16, 14, 12, 10, 9, 8];
      const maxY=200; // upper bound
      // axes
      cx.clearRect(0,0,w,h); cx.translate(pad,pad);
      cx.strokeStyle='rgba(255,255,255,.25)'; cx.lineWidth=1;
      cx.beginPath(); cx.moveTo(0,0); cx.lineTo(0,H); cx.lineTo(W,H); cx.stroke();
      // grid
      cx.font='12px system-ui'; cx.fillStyle='rgba(255,255,255,.6)';
      for(let i=0;i<=6;i++){ const x=W*i/6; cx.strokeStyle='rgba(255,255,255,.1)'; cx.beginPath(); cx.moveTo(x,0); cx.lineTo(x,H); cx.stroke(); cx.fillText('D'+(i+1), x-8, H+16); }
      for(let gy=0; gy<=4; gy++){ const y=H*gy/4; cx.strokeStyle='rgba(255,255,255,.1)'; cx.beginPath(); cx.moveTo(0,y); cx.lineTo(W,y); cx.stroke(); cx.fillText((maxY - maxY*gy/4).toFixed(0), -32, y+4); }
      // line helper
      function line(series, color){
        cx.strokeStyle=color; cx.lineWidth=2; cx.beginPath();
        series.forEach((v,i)=>{ const x=W*(i/(series.length-1)); const y=H*(1 - v/maxY); if(i===0) cx.moveTo(x,y); else cx.lineTo(x,y); });
        cx.stroke();
      }
      line(crp,'rgba(124,249,210,.95)'); // CRP
      // scale WBC to CRP axis (multiply by ~10)
      line(wbc.map(v=>v*10),'rgba(167,139,250,.95)');
      // legend
      cx.fillStyle='rgba(255,255,255,.8)';
      cx.fillRect(W-160,10,150,46);
      cx.fillStyle='#0b1020'; cx.fillText('Legend', W-150, 26);
      cx.fillStyle='rgba(124,249,210,1)'; cx.fillRect(W-150, 32, 10, 2);
      cx.fillStyle='#0b1020'; cx.fillText('CRP (mg/L)', W-134, 36);
      cx.fillStyle='rgba(167,139,250,1)'; cx.fillRect(W-150, 46, 10, 2);
      cx.fillStyle='#0b1020'; cx.fillText('WBC (×10⁹/L) ×10', W-134, 50);
      cx.setTransform(1,0,0,1,0,0);
    }
    new ResizeObserver(drawChart).observe(document.getElementById('cases'));

    // -------------------- PAPERS: COPY VISIBLE --------------------
    document.getElementById('copyVisible').onclick=()=>{
      const items=[...document.querySelectorAll('#paperList .paper')].filter(x=>x.style.display!=="none");
      const text=items.map(x=>{
        const title=x.querySelector('strong')?.textContent?.trim();
        const link=x.querySelector('a')?.href; return `${title} — ${link}`;
      }).join('\n');
      navigator.clipboard.writeText(text).then(()=>{
        const b=document.getElementById('copyVisible'); const t=b.textContent; b.textContent='Copied!'; setTimeout(()=>b.textContent=t,1200);
      });
    };

    // -------------------- MISC: PRINT + TO TOP --------------------
    document.getElementById('printBtn').onclick=()=>window.print();
    const toTop=document.getElementById('toTop');
    window.addEventListener('scroll',()=>{toTop.style.display=window.scrollY>600?'block':'none'});
    toTop.onclick=()=>window.scrollTo({top:0, behavior:'smooth'});
  </script>
</body>
</html>
